Hydroxychloroquine

Hydroxychloroquine (CAS 118-42-3) is an aminoquinoline compound used as an active pharmaceutical ingredient in the treatment of autoimmune conditions and malaria. It is commercially supplied primarily as hydroxychloroquine sulfate, the salt form used in finished dosage manufacturing.

The primary application is in the manufacture of oral tablet formulations targeting rheumatoid arthritis, lupus erythematosus, and malaria prophylaxis. Contract manufacturers and generic drug producers source it as a regulated API for solid dosage form production.

Pharmaceutical formulators also use it in clinical trial supply chains where precise purity specifications and documented sourcing are critical to regulatory submissions. Research institutions and API developers source it as a reference standard.

It is also utilized as an intermediate in quinoline-based drug development programs. Hydroxychloroquine is commercially available as a white to off-white crystalline powder, predominantly in the sulfate salt form.

Supply is offered under pharmaceutical-grade specifications compliant with USP and BP monographs. Quantities range from research-scale packaging to bulk API volumes for industrial use.

GMP-certified documentation is typically required for regulated market supply to ensure safety and efficacy. Our supply chain ensures that all quality standards are met for global distribution and manufacturing needs.